PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30448265-7	2019	RESULTS: The anti-diabetic effects of eugenol were demonstrated by the significant reduction in the levels of serum glucose, triglyceride, cholesterol, Low-density lipoprotein, malondialdehyde and interleukin-6 in the treated group compared to the diabetic group.	Eugenol	38-45	interleukin 6	Rattus norvegicus	197-210	
35101571-12	2022	Pre-treatment with eugenol on the ethanol-induced ulcer reduced the plasma NO levels and increased PGE2 along with a decreased TNF-alpha and IL-6 concentration.	Eugenol	19-26	interleukin 6	Rattus norvegicus	141-145	
30668414-16	2019	The levels of TNF-alpha, IL-6 and IL-10 were also ameliorated by cinnamaldehyde and eugenol treatment.	Eugenol	84-91	interleukin 6	Rattus norvegicus	25-29	
30233696-7	2018	Compared with the control group, the eugenol treatment significantly reduced the myocardial malondialdehyde content, serum cardiac troponin I, creatine kinase-MB, tumor necresis factor-alpha and interleukin-6 levels (P<0.05) and significantly alleviated myocardial injury.	Eugenol	37-44	interleukin 6	Rattus norvegicus	195-208